Our 3rd Data Partner Call is now closed! Next Call in 2021


OHDSI and EHDEN Partners Obtain Grant Towards Global Research On COVID-19 Treatments

An international cohort of OHDSI collaborators obtained a grant from the COVID-19 Therapeutics Accelerator...

Read More
EHDEN Certifies 10 European SMEs in the mapping of data to the OMOP CDM.

On the 4th and 5th of August, EHDEN organised a virtual certification meeting, inviting...

Read More
New Academy course now available: Learn all about the ATLAS tool!

We are pleased to announce that we’ve just launched a new course in the...

Read More
EHDEN now working with 28 Data Partners across 11 countries to harmonise clinical data across therapeutic areas including COVID-19

28 July 2020, Brussels, Belgium. Healthcare today is ever more complex, with growing expectations...

Read More

Posts Navigation

Welcome to the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 22 partners which will operate in Europe for the coming five years, 2018 – 2024.

EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.

At this time, the thoughts of all those involved in the EHDEN project are with those ill with COVID-19, and those who are looking after them at home or in hospitals.

Clearly, we are all affected by this evolving pandemic, and equally, the project will be impacted by it, but we will aim to mitigate this as best as practicable.

EHDEN is proud to have collaborated with OHDSI colleagues in ongoing studies since March on COVID-19, see more information here and on the OHDSI website here.

Our best wishes to all, stay safe and well.



No event found!